Impact of Reimbursement for Biomarker Testing on Clinical Practice

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”

Related Videos

October 16, 2015

A Look Into Anti-PD-1 and Anti-PD-L1 Therapies

Dr. Sanjiv Agarwala analyzes anti-PD-1 and anti-PD-L1 therapies in terms what they do and their unique toxicities and response patterns.

September 20, 2013

Realizing the Value in Personalized Medicine

Jennifer Malin discusses the aspects of value and how they are realized in personalized medicine